YNIOS Pharma

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": "0538.839.354",
          "rrn": null,
          "kind": "org",
          "name": "SPREDS FINANCE",
          "share_class": "B1",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 74500,
          "contribution_amount_eur": 74500.0
        }
      ],
      "share_emission": {
        "agio_eur": 0.0,
        "share_form": "no_nominal_value",
        "share_class": "B1",
        "n_new_shares": 74500,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1.0
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Pascal VAN HOVE",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-12-06",
    "filing_date": "2024-12-03",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_g\u00E9n\u00E9rale_extraordinaire",
    "act_date": "2024-08-08",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full": "YNIOS Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": "0538.839.354",
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": "aandeelhouder",
      "n_shares": 74500,
      "share_class": "B1"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Pascal VAN HOVE",
      "role": "aandeelhouder",
      "n_shares": 87400,
      "share_class": "B2"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 5370000,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 187100,
      "class_name": "B1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 300000,
      "class_name": "B2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 2700,
      "class_name": "B3",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 200000,
      "class_name": "B4",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-12-06",
    "filing_date": "2024-12-03",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS, DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-08-08",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full_after": "YNIOS Pharma",
    "legal_form_after": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "name_full_before": "YNIOS Pharma",
    "current_zetel_raw": "Chemin de l\u2019Yerne, 6C 4537 Verlaine",
    "legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "David REMY",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Remplace le texte de l\u0027article 5 des statuts par un nouveau texte d\u00E9taillant l\u0027\u00E9mission et la r\u00E9partition des actions en cinq cat\u00E9gories.",
      "new_text": "Article 5. Apports\nEn r\u00E9mun\u00E9ration des apports, 6.059.800 actions ont \u00E9t\u00E9 \u00E9mises, r\u00E9parties en 5 cat\u00E9gories :\n \u2022 5.370.000 actions de cat\u00E9gorie A (FONDATEURS) ;\n \u2022 187.100 actions de cat\u00E9gorie B1 (SPREDS FINANCE Tax Shelter) ;\n \u2022 300.000 actions de cat\u00E9gorie B2 (PRIVES Tax Shelter) ;\n \u2022 2.700 actions de cat\u00E9gorie B3 (SPREDS FINANCE Normal) ;\n \u2022 200.000 actions de cat\u00E9gorie B4 (PRIVES Normal).\nChaq",
      "change_kind": "replaced",
      "article_title": "Apports",
      "article_number": "5"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "David REMY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": null,
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": false
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": null,
    "share_classes_after": [
      {
        "count": 74500,
        "label": "B1",
        "rights_summary": "Souscription nouvelle, r\u00E9gime Tax Shelter",
        "voting_per_share": null
      },
      {
        "count": 300000,
        "label": "B2",
        "rights_summary": "PRIVES Tax Shelter",
        "voting_per_share": null
      },
      {
        "count": 2700,
        "label": "B3",
        "rights_summary": "SPREDS FINANCE Normal",
        "voting_per_share": null
      },
      {
        "count": 200000,
        "label": "B4",
        "rights_summary": "PRIVES Normal",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "stage": null,
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-10",
    "filing_date": "2024-06-06",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS, DIVERS"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-03-19",
    "unanimous": null
  },
  "conversion": {
    "effective_date": null,
    "jurisdiction_to": null,
    "legal_form_after": null,
    "jurisdiction_from": null,
    "legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "detected_kind": "conversion_legal_form",
  "report_waiver": {
    "summary": "The shareholders waived their preferential subscription right under article 7 of the statutes.",
    "articles": [
      "7"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0783.494.239",
        "name": "YNIOS Pharma",
        "role": "contributor",
        "address": "Chemin de l\u2019Yerne, 6C, 4537 Verlaine",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0538.839.354",
        "name": "SPREDS FINANCE",
        "role": "contributor",
        "address": null,
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Pascal VAN HOOVE",
        "role": "contributor",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Ilse DE GROOTE",
        "role": "contributor",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 5985300,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full": "YNIOS Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "David REMY",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de YNIOS Pharma a pris des r\u00E9solutions pour augmenter le nombre d\u0027actions, cr\u00E9er de nouvelles cat\u00E9gories d\u0027actions et souscrire \u00E0 ces nouvelles actions aupr\u00E8s de partenaires certifi\u00E9s et d\u0027investisseurs priv\u00E9s. Parall\u00E8lement, les statuts ont \u00E9t\u00E9 modifi\u00E9s pour refl\u00E9ter ces apports.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": {
    "prior_pub_date": "2022-03-18",
    "what_corrected": null,
    "prior_pub_number": "22318105"
  },
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": "0538.839.354",
          "rrn": null,
          "kind": "org",
          "name": "SPREDS FINANCE",
          "share_class": "B1",
          "liberation_pct": 100.0,
          "contribution_kind": null,
          "n_shares_subscribed": 7600,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "B1",
        "n_new_shares": 7600,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": "0538.839.354",
          "rrn": null,
          "kind": "org",
          "name": "SPREDS FINANCE",
          "share_class": "B2",
          "liberation_pct": 100.0,
          "contribution_kind": null,
          "n_shares_subscribed": 87400,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "B2",
        "n_new_shares": 87400,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 87400,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": "0538.839.354",
          "rrn": null,
          "kind": "org",
          "name": "SPREDS FINANCE",
          "share_class": "B3",
          "liberation_pct": 100.0,
          "contribution_kind": null,
          "n_shares_subscribed": 2700,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "B3",
        "n_new_shares": 2700,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 2700,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Pascal VAN HOOVE",
          "share_class": "B4",
          "liberation_pct": 100.0,
          "contribution_kind": null,
          "n_shares_subscribed": 87600,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Ilse DE GROOTE",
          "share_class": "B4",
          "liberation_pct": 100.0,
          "contribution_kind": null,
          "n_shares_subscribed": 25000,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "B4",
        "n_new_shares": 112600,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 112600,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-06-10",
    "filing_date": "2024-06-06",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2024-03-19",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full": "YNIOS Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": "0538.839.354",
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": null,
      "n_shares": 5370000,
      "share_class": "A"
    },
    {
      "kbo": "0538.839.354",
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": null,
      "n_shares": 112600,
      "share_class": "B1"
    },
    {
      "kbo": "0538.839.354",
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": null,
      "n_shares": 387400,
      "share_class": "B2"
    },
    {
      "kbo": "0538.839.354",
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": null,
      "n_shares": 2700,
      "share_class": "B3"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Pascal VAN HOOVE",
      "role": null,
      "n_shares": 87600,
      "share_class": "B4"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Ilse DE GROOTE",
      "role": null,
      "n_shares": 25000,
      "share_class": "B4"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 5370000,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 112600,
      "class_name": "B1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 387400,
      "class_name": "B2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 2700,
      "class_name": "B3",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 112600,
      "class_name": "B4",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 5575000,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": 200000.0,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "PASCAL VAN HOVE",
          "share_class": "B2",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 100000,
          "contribution_amount_eur": 100000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Madame DE GROOTE Ilse Leonce",
          "share_class": "B2",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 100000,
          "contribution_amount_eur": 100000.0
        }
      ],
      "share_emission": {
        "agio_eur": 0.0,
        "share_form": null,
        "share_class": "B2",
        "n_new_shares": 200000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 200000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "other",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-01-25",
    "filing_date": "2023-01-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
    "act_date": "2023-01-17",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full": "YNIOS Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 5370000,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 105000,
      "class_name": "B1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 300000,
      "class_name": "B2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "SPREDS FINANCE",
          "share_class": "B1",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 105000,
          "contribution_amount_eur": 105000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "VAN HOVE Pascal Urbain",
          "share_class": "B2",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 100000,
          "contribution_amount_eur": 100000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    }
  ],
  "notary": {
    "name": "David REMY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Fernelmont",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-09-28",
    "filing_date": "2022-09-26",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-09-06",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0783.494.239",
    "name_full": "YNIOS Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Ghislaine",
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": "0783.494.239",
      "pct": null,
      "kind": "org",
      "name": "YNIOS Pharma",
      "role": "aandeelhouder",
      "n_shares": 5370000,
      "share_class": "A"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "SPREDS FINANCE",
      "role": "aandeelhouder",
      "n_shares": 105000,
      "share_class": "B1"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "VAN HOVE Pascal Urbain",
      "role": "aandeelhouder",
      "n_shares": 100000,
      "share_class": "B2"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 5370000,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 105000,
      "class_name": "B1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 100000,
      "class_name": "B2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}